Mutational re-modeling of di-aspartyl intramembrane proteases: uncoupling physiologically-relevant activities from those associated with Alzheimer’s disease
Year: 2017
Type: article
Abstract: The intramembrane proteolytic activities of presenilins (PSEN1/PS1 and PSEN2/ PS2) underlie production of β-amyloid, the key process in Alzheimer's disease (AD).Dysregulation of presenilin-mediated signaling is linked to cancers.Inhibition of the γ-cleavage activities of PSENs that produce Aβ, but not the ε-like cleavage activity that release physiologically essential transcription activators, is a potential approach for the development of rational therapies for AD.In order to identify whether different activities of PSEN1 can be dissociated, we designed multiple mutations in the evolutionary conserved sites of PSEN1.We tested them in vitro and in vivo assays and compared their activities with mutant isoforms of presenilin-related intramembrane di-aspartyl protease (IMPAS1 (IMP1)/signal peptide peptidase (SPP)).PSEN1 autocleavage was more resistant to the mutation remodeling than the ε-like proteolysis.PSEN1 with a G382A or a P433A mutation in evolutionary invariant sites retains functionally important APP ε-and Notch S3-cleavage activities, but G382A inhibits APP γ-cleavage and Aβ production and a P433A elevates Aβ.The G382A variant cannot restore the normal cellular ER Ca 2+ leak in PSEN1/PSEN2 double knockout cells, but efficiently rescues the loss-of-function (Egl) phenotype of presenilin in C. elegans.We found that, unlike in PSEN1 knockout cells, endoplasmic reticulum (ER) Ca 2+ leak is not changed in the absence of IMP1/SPP.IMP1/SPP with the analogous mutations retained efficiency in cleavage of transmembrane substrates and rescued the lethality of Ce-imp-2 knockouts.In summary, our data show that mutations near the active catalytic sites of intramembrane di-aspartyl proteases have different consequences on proteolytic and signaling functions.
Source: Oncotarget
Institutions: Russian Academy of Sciences, University of Massachusetts Chan Medical School, Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences, Vavilov Institute of General Genetics, The University of Texas Southwestern Medical Center, Lomonosov Moscow State University
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
Funders: Mayo Clinic, Alzheimer's Association, University of Massachusetts, Russian Science Foundation, Tokyo Women's Medical University, National Institutes of Health, University of Massachusetts Medical School, Research Institute for Microbial Diseases, Osaka University, National Institute on Aging, National Institute of Neurological Disorders and Stroke, Institute of Genetics
OpenAlex ID: W2620117313
